Sign in

NCT06858306Active, not recruiting

SPHERE Per-AF Post-Approval Study

SPHERE Per-AF Post-Approval Study, an Addendum to the Affera Global Registry

Source: ClinicalTrials.gov · Last updated 18 Jun 2026

Brief summary (registry, in English)

SPHERE Per-AF Post-Approval Study is a prospective, multi-center, non-randomized, observational trial. Subjects will be treated with the Sphere-9™ Catheter and Affera™ Ablation System and followed through 36 months.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
26 Feb 2025
Start date
25 Sept 2025
Primary completion date
Oct 2030
Lead sponsor
Medtronic Cardiac Ablation Solutions
NCT number
NCT06858306

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 25 Sept 2025 to the primary completion date, Oct 2030
  • 14 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior left atrial catheter or surgical ablation
  • Current or anticipated participation in any other clinical trial of a drug, device or biologic during the duration of this study not pre-approved by Medtronic

Other illness

  • Presence of a permanent pacemaker, biventricular pacemaker, loop recorder/insertable cardiac monitor (ICM), or any type of implantable cardiac defibrillator (with or without biventricular pacing function)

Other

  • Long-standing persistent AF (continuous AF sustained \>12 months)
  • Life expectancy \<36 months

Who the study is looking for

  • A diagnosis of recurrent symptomatic persistent AF (continuous AF sustained longer than 7 days but less than 12 months)
  • Refractory (i.e. not effective, not tolerated, or not desired) to at least one Class I or III antiarrhythmic drug (AAD)
  • Patient is ≥ 18 years of age
  • Planned de novo pulmonary vein isolation procedure using commercially available Sphere-9™ Catheter and Affera Ablation System
  • Patient is willing and able to comply with study requirements and give informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (14)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Piedmont Heart Institute
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
University of Alabama At Birmingham Hospital
Coordinator of this site? Confirm its status
BirminghamUnited StatesUnknown status
Atrium Health - Carolinas Medical Center
Coordinator of this site? Confirm its status
CharlotteUnited StatesUnknown status
University of Virginia Medical Center
Coordinator of this site? Confirm its status
CharlottesvilleUnited StatesUnknown status
OhioHealth
Coordinator of this site? Confirm its status
ColumbusUnited StatesUnknown status
Doylestown Health Cardiology
Coordinator of this site? Confirm its status
DoylestownUnited StatesUnknown status
Texas Health Resources
Coordinator of this site? Confirm its status
Fort WorthUnited StatesUnknown status
Houston Methodist Hospital
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
Centra Medical Group Stroobants Cardiovascular Center
Coordinator of this site? Confirm its status
LynchburgUnited StatesUnknown status
Minneapolis Heart Institute Foundation
Coordinator of this site? Confirm its status
MinneapolisUnited StatesUnknown status
Montefiore Medical Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
Allegheny General Hospital
Coordinator of this site? Confirm its status
PittsburghUnited StatesUnknown status
Mayo Clinic
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status
Sarasota Memorial Hospital
Coordinator of this site? Confirm its status
SarasotaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.